Big Gain For Lineage Cell Therapeutics, Inc.
Wed, Apr 28, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) rocketted at $43.73, representing a gain of 75.6%. On Tue, Apr 27, 2021, BTX:NYSEMKT hit a New 2-Week High of $24.9. The stock got featured on our News Catalysts scanner on Mon, Apr 26, 2021 at 08:48 AM in the 'MISCELLANEOUS' category. From Tue, Apr 13, 2021, the stock recorded 80.00% Up Days and 54.55% Green Days
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- Companhia Paranaense de Energia - COPEL (ELP:NYSE), 411.5%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 75.62%
- Uxin Limited (UXIN:NASDAQ), 45.32%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 44.77%
- U.S. Well Services, Inc. (USWS:NASDAQ), 26.65%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 22.6%
- Aurora Mobile Limited (JG:NASDAQ), 19.6%
- Millendo Therapeutics, Inc. (MLND:NASDAQ), 18.9%
- Shineco, Inc. (TYHT:NASDAQ), 17.67%
- ClearSign Technologies Corporation (CLIR:NASDAQ), 16.28%